Genetic Polymorphisms of CYP3A5, CHRM2, and ZNF498 and Their Association With Epilepsy Susceptibility: A Pharmacogenetic and Case–control Study
Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s212433
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2019
Authors
Publisher
Informa UK Limited